Cargando…

Transitioning from epicutaneous to oral peanut immunotherapy

INTRODUCTION: Epicutaneous immunotherapy (EPIT) has been tested in clinical trials for children with peanut allergy (PA) for its safety and efficacy in inducing desensitization. Aside from peanut avoidance and symptom management, oral immunotherapy (OIT) is another option for PA patients. However, O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Lauren, Kost, Laurie, Anderson, Brent, Long, Andrew, Sindher, Sayantani B., Chinthrajah, R. Sharon, Collins, William J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Allergy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939758/ https://www.ncbi.nlm.nih.gov/pubmed/36814725 http://dx.doi.org/10.3389/falgy.2023.1089308

Ejemplares similares

Oral immunotherapy for peanut allergy: The pro argument
por: Chinthrajah, R. Sharon, et al.
Publicado: (2020)

Transitioning peanut oral immunotherapy to clinical practice
por: Lazizi, S., et al.
Publicado: (2022)

Virtual Reality Reduces Pediatric Anxiety During Food Allergy Clinical Trials: A Pilot Randomized, Pragmatic Study
por: Alonzi, Sarah, et al.
Publicado: (2022)

Recent advances in epicutaneous immunotherapy and potential applications in food allergy
por: Hervé, Pierre-Louis, et al.
Publicado: (2023)

Food allergy risks and dining industry – an assessment and a path forward
por: Stankovich, Gabriel A., et al.
Publicado: (2023)

Home-Based Peanut Oral Immunotherapy for Low-Risk Peanut-Allergic Preschoolers During the COVID-19 Pandemic and Beyond
por: Chua, Gilbert T., et al.
Publicado: (2021)

Immune signatures predicting the clinical outcome of peanut oral immunotherapy: where we stand
por: Wanniang, Naphisabet, et al.
Publicado: (2023)

Advances and potential of omics studies for understanding the development of food allergy
por: Sindher, Sayantani B., et al.
Publicado: (2023)

Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities
por: Davis, Carla M., et al.
Publicado: (2022)

Reduction in peanut reaction severity during oral challenge after 12 months of epicutaneous immunotherapy
por: Bégin, Philippe, et al.
Publicado: (2021)

Shrimp‐allergic patients in a multi‐food oral immunotherapy trial
por: Nguyen, Diem‐Tran I., et al.
Publicado: (2021)

Oral Immunotherapy in Children: Clinical Considerations and Practical Management
por: Anderson, Brent, et al.
Publicado: (2021)

Pediatric eosinophilic esophagitis outcomes vary with co-morbid eczema and pollen food syndrome
por: Sessions, Julia, et al.
Publicado: (2022)

Peanut butter feeding induces oral tolerance in genetically diverse collaborative cross mice
por: Immormino, Robert M., et al.
Publicado: (2023)

Triclosan promotes epicutaneous sensitization to peanut in mice
por: Tobar, Steven, et al.
Publicado: (2016)

Epicutaneous Immunotherapy (EPIT) Blocks the Allergic Esophago-Gastro-Enteropathy Induced by Sustained Oral Exposure to Peanuts in Sensitized Mice
por: Mondoulet, Lucie, et al.
Publicado: (2012)

Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice
por: Mondoulet, Lucie, et al.
Publicado: (2012)

Peanut Oral Immunotherapy: a Current Perspective
por: Patrawala, Meera, et al.
Publicado: (2020)

Identification of Pru du 6 as a potential marker allergen for almond allergy
por: Kabasser, Stefan, et al.
Publicado: (2020)

Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut
por: Dioszeghy, Vincent, et al.
Publicado: (2017)

Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study)
por: Chebar Lozinsky, Adriana, et al.
Publicado: (2020)

Manufacturing processes of peanut (Arachis hypogaea) allergen powder-dnfp
por: Leonard, Stephanie A., et al.
Publicado: (2022)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

Preclinical evaluation of alternatives to oral immunotherapy for food allergies
por: Johnson-Weaver, Brandi T.
Publicado: (2023)

Mechanisms for Alternaria alternata Function in the Skin During Induction of Peanut Allergy in Neonatal Mice With Skin Barrier Mutations
por: Buelow, Lauren M., et al.
Publicado: (2021)

Epicutaneous Immunotherapy for Aeroallergen and Food Allergy
por: Senti, Gabriela, et al.
Publicado: (2013)

Innovative delivery systems for epicutaneous immunotherapy
por: Wang, Zhen, et al.
Publicado: (2023)

Living with food allergies: the experiences of adult patients and caregivers
por: Santos, Alexandra F., et al.
Publicado: (2023)

CD8(+) T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapy
por: Kaushik, Abhinav, et al.
Publicado: (2022)

Determination of Allergen Levels, Isoforms, and Their Hydroxyproline Modifications Among Peanut Genotypes by Mass Spectrometry
por: Marsh, Justin T., et al.
Publicado: (2022)

Recent Mechanistic Studies in Allergic Diseases
por: Sindher, Sayantani B., et al.
Publicado: (2023)

Asthma as a predictor of more severe outcomes in COVID-19 infection
por: Eggert, Lauren, et al.
Publicado: (2021)

Estimating the Risk of Severe Peanut Allergy Using Clinical Background and IgE Sensitization Profiles
por: Datema, Mareen R., et al.
Publicado: (2021)

Masked Delivery of Allergen in Nanoparticles Safely Attenuates Anaphylactic Response in Murine Models of Peanut Allergy
por: Hughes, Kevin R., et al.
Publicado: (2022)

Differences in Linear Epitopes of Ara h 9 Recognition in Peanut Allergic and Tolerant, Peach Allergic Patients
por: Sánchez-Ruano, L., et al.
Publicado: (2022)

SARS-CoV-2 and Perceived Physical, Mental and Social Health in Northern California
por: Fast, Katharine, et al.
Publicado: (2022)

Efficacy of epicutaneous immunotherapy (EPIT) in a new model of peanut-induced eosinophilic esophagitis (EoE) and allergic enterpathy (AE)
por: Mondulet, Lucie, et al.
Publicado: (2011)

The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice
por: Dioszeghy, V, et al.
Publicado: (2014)

Venom Immunotherapy and Aeroallergen Immunotherapy: How Do Their Outcomes Differ?
por: Incorvaia, Cristoforo, et al.
Publicado: (2022)

Innovative Systems to Deliver Allergen Powder for Epicutaneous Immunotherapy
por: Wang, Yensheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dqn2dpc7ugonc1vq1l35s71rar